Cost-Effectiveness of Fidaxomicin for Clostridium difficile Treatment

被引：2
|
作者：
Simon, Matthew S. [1 ,2 ]
机构：
[1] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[2] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY 10065 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 58卷 / 04期
关键词：
VANCOMYCIN; INFECTION; CANCER;
D O I：
10.1093/cid/cit772
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF BEZLOTOXUMAB AND FIDAXOMICIN FOR RECURRENT C. DIFFICILE INFECTION
    Chen, J.
    Gong, C.
    Hitchcock, M. M.
    Holubar, M.
    Deresinski, S.
    Hay, J. W.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [22] A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
    Maureen Watt
    Charles McCrea
    Sukhvinder Johal
    John Posnett
    Jameel Nazir
    Infection, 2016, 44 : 599 - 606
  • [23] A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany
    Watt, Maureen
    McCrea, Charles
    Johal, Sukhvinder
    Posnett, John
    Nazir, Jameel
    INFECTION, 2016, 44 (05) : 599 - 606
  • [24] Fidaxomicin, a new treatment for Clostridium difficile infections
    Cattoir, V.
    Tattevin, P.
    JOURNAL DES ANTI-INFECTIEUX, 2012, 15 (01) : 32 - 38
  • [25] Cost-Effectiveness of Competing Treatment Strategies for Clostridium difficile Infection: A Systematic Review
    Phuc Le
    Nghiem, Van T.
    Mullen, Patricia Dolan
    Deshpande, Abhishek
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2018, 39 (04): : 412 - 424
  • [26] Outcomes of Fidaxomicin Treatment of Clostridium difficile Infection
    Spiceland, Clayton
    Khanna, Sahil
    Pardi, Darrell
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S196 - S196
  • [27] FIDAXOMICIN, A NEW TREATMENT FOR CLOSTRIDIUM DIFFICILE INFECTIONS
    Epstein, L.
    Golan, Y.
    DRUGS OF TODAY, 2012, 48 (02) : 101 - 108
  • [28] Outcomes of Fidaxomicin Treatment of Clostridium difficile Infection
    Spiceland, Clayton M.
    Saffouri, George
    Pardi, Darrell
    Khanna, Sahil
    GASTROENTEROLOGY, 2016, 150 (04) : S744 - S744
  • [29] Effectiveness and cost-effectiveness of a Clostridium difficile vaccine candidate in a hospital setting
    Champredon, David
    Shoukat, Affan
    Moghadas, Seyed M.
    VACCINE, 2020, 38 (11) : 2585 - 2591
  • [30] FIDAXOMICIN TREATMENT FOR CLOSTRIDIUM DIFFICILE IN ALLOGENEIC TRANSPLANT RECIPIENTS
    Salmi, T.
    Oksi, J.
    Salmenniemi, U.
    Putkonen, M.
    Kauppila, M.
    Oksman, M.
    Remes, K.
    Itala-Remes, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S334 - S334
12345